April 26, 2024 07:47 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Justice MB Snehalatha takes oath as additional judge of Kerala High Court | NIA arrests key accused in pro-Khalistani attack on Indian Mission in London | Plea filed in Calcutta HC seeking action against Mamata Banerjee's 'judges purchased' remark | LS polls: 88 seats across 13 states, UTs going to polls tomorrow for phase 2; 1202 candidates in fray | 'Neither shocked nor surprised': Mallikarjun Kharge writes open letter to PM Modi over Congress manifesto row
Kolkata's leading clinical trial specialist Dr Subhrajyoti Bhowmick felicitated

Kolkata's leading clinical trial specialist Dr Subhrajyoti Bhowmick felicitated

India Blooms News Service | @indiablooms | 16 Sep 2021, 12:42 pm

Kolkata/IBNS: Kolkata's leading clinical trial specialist and Director of Peerless Hospital, Dr Subhrajyoti Bhowmick, was bestowed with the "Clinical Research Development and Excellence Award 2021" at the Higher Education and Research Summit 2021 held recently in the city.

Dr Bhwomick has been in the forefront of clinical trials of COVID vaccines in Kolkata and has gained much appreciation for his unstinted efforts He conducted two Russian made  Sputnik vaccine trials at his hospital along withTocilizumab trials also.

The summit was organized jointly by Confederation of Indian Universities, New Delhi and IBRF, Kolkata to award the extraordinary teachers and researchers who have contributed during the Covid19 Pandemic in India.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.